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Regulating the transition of cells such as T lymphocytes from quiescence (G0) into an activated,
proliferating state involves initiation of cellular programs resulting in entry into the cell cycle
(proliferation), the growth cycle (blastogenesis, cell size) and effector (functional) activation. We
showtheﬁrstproteomicanalysisofproteininteractionnetworksactivatedduringentryintotheﬁrst
cell cycle from G0. We also provide proof of principle that blastogenesis and proliferation programs
areseparableinprimaryhumanTcells.Weemployedaproteomicproﬁlingmethodtoidentifylarge-
scale changes in chromatin/nuclear matrix-bound and unbound proteins in human T lymphocytes
during the transition from G0 into the ﬁrst cell cycle and mapped them to form functionally
annotated, dynamic protein interaction networks. Inhibiting the induction of two proteins involved
in two of the most signiﬁcantly upregulated cellular processes, ribosome biogenesis (eIF6) and
hnRNA splicing (SF3B2/SF3B4), showed, respectively, that human T cells can enter the cell cycle
without growing in size, or increase in size without entering the cell cycle.
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Introduction
Quiescence(G0)isanactivelymaintainedstate(Liu,2005)and
quiescent cells, such as non-activated peripheral blood Tcells
do not contain many of the proteins necessary for cell
proliferation (Thomas et al, 1998; Lea et al, 2003; reviewed
inThomas, 2004; Coller, 2007). Forthisreason,Tcellsentering
the cell cycle for the ﬁrst time take 32–40h to enter S-phase as
compared with the 25.6h it takes actively cycling cells to
complete one entire cell cycle (Lea et al, 2003). Presentation of
antigen to a memory T cell by an antigen-presenting cell
triggers signal transduction through the T-cell receptor (CD3)
and co-stimulatory molecules such as CD28, which results in
T-cell activation and clonal expansion (Acuto and Michel,
2003). Programs are thus initiated (van Leeuwen and
Samelson, 1999; van Oers, 1999) that lead to T-cell prolifera-
tion, increase in cell size (blastogenesis) and the induction of
effector molecules (activation), which include cytokines and
cell surface receptors (Mosmann et al, 1986; Jain et al, 1995).
We previously identiﬁed a G0-G1 commitment point (CP) in
primary human T cells that controls entry into the cell cycle
from quiescence (Lea et al, 2003), which provided proof of
principle that entry into the cell cycle and cellulargrowth cycle
can be uncoupled from early expression of T-cell effector
(activation) functions, such as production of IL-2, g-IFN and
cell surface CD69, CD44 and CD62L.
In order to expand upon this work, we sought to identify
cellular pathways and regulatory proteins that are activated or
repressed in primary human Tcells as they enter the cell cycle
for the ﬁrst time. We focused our analyses on changes in
proteins associated with chromatin and the nuclear matrix
(C/NM), asthesenuclearstructuresarelikelytobeinvolvedin
the direct regulation of a number of important processes. The
nuclear matrix (reviewed in Nickerson, 2001) binds proteins
that can form spatially distinct macromolecular complexes
involved in transcription (Misteli, 2004; Zink et al, 2004), RNA
splicing and transport, as well as DNA replication (Anachkova
et al, 2005). However, dynamic changes in the composition of
the C/NM-bound proteome during cell-cycle entry have not
been characterized.
In the current study, we utilized a label-free mass spectro-
metry-based approach to identify C/NM-associated proteins,
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humanTcellsastheyenterthecell cycle. We report for theﬁrst
time on the protein interaction networks that are regulated
during this cell-cycle transition and identify both known and
novel aspects of T-cell activation during cell-cycle entry. We
showalso that entry into the cell cycle and growthcycle can be
separated in primary human Tcells: the SF3B splicing factor is
needed for entry into the cell cycle but not the growth cycle,
whereas eIF6, which is involved in 60S ribosome biogenesis,
regulates entry into the growth cycle but not the cell cycle. Our
dataprovideproofofprinciple thatentry intothecell cycleand
growthcycleareseparableandthathumanTcellscanenterthe
cell cycle at a restricted size.
Results
Identiﬁcation of chromatin/nuclear matrix-bound
proteins in G0 and G1
Toidentifyproteinsthatchangeduringentryintothecellcycle,
we used human non-activated, quiescent (G0) Tcells from the
peripheral blood of four normal donors, which have normal
cellular mechanisms. We isolated near 100% non-activated,
quiescent cells and cells 40h post-stimulation with PMA/io-
nomycin, when 20.3%±3.46 (mean±s.e.m., n¼8) had
entered S-phase (Supplementary Figure S1A), o1% had
divided once (Lea et al, 2003) and were activated (Supple-
mentary Figure S1B). We use a well-established method
throughout to measure protein content by FITC staining as a
proxy for entry into the growth cycle (Darzynkiewicz et al,
1982), which has been used for many published cell-cycle
studies,includingourown(Thomasetal,1991,1998;Leaetal,
2003; Orr et al, 2010). This approach correlates well with
forward-scatter (FSC) analyses of cell size (Supplementary
Figure S1C). Typically, quiescent and stimulated cells were
kept in culture for the same periods and the results below do
not simply reﬂect hours in culture.
Cell fractions enriched for C/NM-bound proteins as well as
unbound (free) proteins were isolated from the quiescent and
stimulated T cells by CSK extraction, as described previously
(Lea et al, 2003; Orr et al, 2010; modiﬁed from Krude et al,
1996). The extracts were trypsinized and proteins were
identiﬁed by LC-MS/MS (Washburn et al, 2001). Initial
MudPIT experiments identiﬁed 611 proteins, of which 250
increased in C/NM binding in G1 (see Supplementary Results;
Supplementary Table S1). To expand upon the initial mass
spectrometry and validation studies, we conducted a second
round of proteomic analyses, this time utilizing an LTQ-
Orbitrap mass spectrometer (Thermo Scientiﬁc) to increase
coverage and improve quantiﬁcation. Samples of C/NM-
bound and -unbound proteins from four biological replicates
of T cells in G0 and 40h þPMA/iomomycin were analyzed,
yielding a total of 2894 proteins identiﬁed with high
conﬁdence (o1% FDR), of which 1724 were observed in the
C/NM-bound and 2653 in the unbound fractions (Supplemen-
tary Table S2). There was an overlap of 595 of the 611 proteins
(97.4%) identiﬁed in the initial experiments, although some
discrepancies were identiﬁed due to a detergent removal step
in the Orbitrap protocol (Supplementary Results). A majority
of proteins identiﬁed in the C/NM-bound fraction (86%) were
also observed in the unbound fraction either due to the
extraction conditions, or because bound and unbound cellular
pools exist (illustrated in Figure 1). Indeed, known C/NM
proteins such as histones and lamins were observed in the
unbound fraction. This is expected for histones as they are
synthesized, assembled into complexes and post-translation-
ally modiﬁed in the cytoplasm before being transported to the
nucleus (Campos et al, 2010). It is possible that other nuclear
complexes are also assembled by a similar mechanism. As
expected, the C/NM fraction was stronglyenriched for nuclear
proteins. GO-term analysis found that 52.4% of bound
proteins were nuclear and/or nucleolar, while 9.1% were
mitochondrial and only 10.8% were primarily cytosolic. The
latter is an overestimate as there are many proteins annotated
as ‘cytosolic,’ which have nuclear forms as well. In all, 3.4% of
proteins in the C/NM fraction were ribosomal. Ribosome
assembly occurs in the nucleolus so it is possible that it is the
nucleolar form of these proteins that is being detected or those
in transit through the nucleus.
Relative abundances of all proteins during cell-cycle entry
were calculated using the APEX method of label-free protein
quantiﬁcation (Lu et al, 2007; Braisted et al, 2008; Vogel and
Marcotte, 2008) (C/NM-bound and -unbound proteins;
Supplementary Tables S3 and S4), with statistically signiﬁcant
changes in protein abundance assessed by a Z-score cutoff
C/NM Free
C/NM Free
C/NM Free
241 1483 1170
258 49 465
162 49 419
A
B
C
Proteins identified
Increased in G1
Decreased in G1
Figure1 SummaryofC/NM-boundand-freefractionproteomicanalysis.(A)A
total of 2894 proteins were identiﬁed at high conﬁdence (o1% FDR) from the
combined C/NM-bound and -free fractions, with 1483 proteins (51.2%) identiﬁed
in both fractions. (B) In all, 772 proteins showed a signiﬁcant increase in
abundance in cells stimulated with PMA/ionomycin as compared with cells in G0
for the C/NM-bound and -free fractions combined, with an overlap of 49 proteins
(6.3%).(C)Atotalof630proteinsshowedasigniﬁcantdecreaseinabundancein
stimulated cells, with an overlap of 49 proteins (7.8%).
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signiﬁcant increase in the abundance of 307 proteins in the C/
NM-bound fraction during cell-cycle entry, while 514 increased
in the unbound fraction. In all, 211 bound proteins decreased
during cell-cycle entry, along with 468 in the unbound. The
overlap between the proteins that increase or decrease in C/
NM-bound and free samples is shown as Venn diagrams
(Figure 1).
Changes in protein abundance for the C/NM-bound and
-unbound fractions can occur either by an overall increase or
decrease in protein abundance, or by changes in protein
localization. The proteomic data do not allow us to easily
distinguish between these two possibilities; however, additional
data did allow us to investigate this further. Gene expression
array analyses showed that there was an increase in mRNA
encoding 44% of the C/NM-bound proteins, which increased
duringcell-cycleentry(SupplementaryTable S5).Wevalidateda
subsetofchangesinC/NM-boundandfreeproteinsidentiﬁedby
our initial mass spectrometry studies by western blotting
(Figure 2). These include examples of proteins such as Topo1,
RUNX3and Mcm7, which exhibit changes in overall abundance,
while others, such as STAT3 and NF-kB p50, are already present
in G0 but become C/NM bound as T cells enter the cell cycle.
These data suggest that regulation of both protein abundance
and localization play a role in changes to C/NM-bound and -free
protein levels as cells enter the cell cycle from G0.
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Figure 2 Validation of proteins identiﬁed by mass spectrometry. A subset of proteins identiﬁed by the mass spectrometry screen to be C/NM bound in G0 or in cells
stimulated with PMA/ionomycin were analyzed by western blotting. The samples analyzed were (A, C, D), total cell lysates of T cells during the G0 or G1 transition
(0–40h þPMA/ionomycin);chromatin/nuclearmatrix-bound(Chr)andunbound(free)proteinsinG0orpost-stimulation(0and40h þPMA/ionomycin);(B),chromatin/
nuclear matrix-bound (Chr) and free samples taken at each of the time points indicated. The patterns of expression and binding for proteins as indicated in (A) are as
follows: (a) proteins, such as Topo I, RUNX3 and Mcm7 are present at a low/undetectable level in G0 and are induced and bind C/NM post-stimulation; (b) proteins such
as STAT3 and NF-kB p50 are present at similar levels in G0 after stimulation but only bind chromatin in stimulated cells; (c) proteins such as Prohibitin and PARP-1 are
present andbind C/NM inG0but the levels ofbinding increasewhen cellsare stimulated withPMA/ionomycin. LSP-1 is anexample of aprotein C/NM bound inG0but is
reduced in stimulated cells. Controls for cell-cycle progression and C/NM-bound versus -unbound proteins and sample loading (Histones stained with Coomassie
Blue and p42/p44 MAPK (ERK1/2)) are shown. Representative of n43 independent experiments for each protein. For each protein analyzed by western blotting,
the fold-change of the C/NM binding between cells in G0 and 40h post-stimulation with PMA/ionomycin, determined by mass spectrometry, is shown in Supplementary
Table S8A. Source data is available for this ﬁgure in the Supplementary Information.
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during the G0-G1 transition
Proteins that increase in binding to C/NM during cell-cycle
entry were assigned to cellular functions by ontology predic-
tions (http://www.geneontology.org) and reading primary
papers. In all, 19.6% are involved in the processing of mRNA
(RNA splicing (7.8%), transport (1%), decay (2.3%), RNA-
binding proteins (3.6%) and RNA helicases (4.9%)), 19.2% in
ribosome biogenesis and 12.4% in transcription (Figure 3A).
However, these simple classiﬁcations hide more complex
functional properties of the proteins identiﬁed, which can be
involved in more than one functional process (see Supple-
mentary Discussion).
We wished to visualize the relationships between the
proteins that we identiﬁed and to establish a dynamic protein
interaction network of changes that occur during cell-cycle
entry. We mapped the sets of proteins exhibiting signiﬁcant
change in abundance onto the HumanNet functional gene
network (Lee et al, 2011a,b) and visualized the resulting maps
with Cytoscape (http://www.cytoscape.org), using the yFiles
organic layout tool (Figure 3B; Supplementary Figure S2B;
networksforbothsetsofdatareportedabovearealsoavailable
as .cys Files 1 and 2, which can be viewed in Cytoscape. See
also high-resolution PDFs of each in Supplementary Figure
S2C and D). The most signiﬁcant subnetworks that became
bound to C/NM during cell-cycle entry include proteins
involved in (1) ribosome biogenesis, nucleolar proteins,
RNA helicases and RNA splicing; (2) ribosome biogenesis;
and (3) nuclear pore complexand splicing proteins(Figure 3B;
Supplementary Table S3). These data are consistent with an
upregulation of gene expression and protein translation that
occurs as quiescent cells enter the cell cycle and proliferate.
More detailed discussion of individual proteins identiﬁed by
our analyses and their cellular functions can be found in
Supplementary Discussion. Subnetworks involved in a
number of cellular processes induced during cell-cycle entry,
such as solute carriers, DNA damage proteins, nuclear pore
complex and others, were also predicted using HumanNet
(Lee et al, 2011a,b) from seed-sets of proteins identiﬁed by the
mass spectrometry screen (see Supplementary Results and
discussion; Supplementary Figure S4A–E; Supplementary
Table S6A–G).
Xin1/Xirp1 is present in the nuclei of human T cells
and becomes induced and bound to C/NM during
cell-cycle entry
The protein that was induced most in both the C/NM-bound
and -free fractions in our mass spectrometry analyses is an
actin-binding protein called Xirp1/Xin1 (Pacholsky et al,
2004), implicated in the differentiation of cardiac muscle cells
and cardiomyocytes (van der Ven et al, 2006; Claeys et al,
2009; Otten et al, 2010). However, Xirp1 has not previously
been reported to be expressed in T cells. To conﬁrm the
ﬁndings of the mass spectrometry analyses, we used western
blotting to analyze the expression of Xirp1 in C/NM and free
fractions of Tcells entering the cell cycle (Figure 4A). Samples
of C/NM-bound and -free fractions from Tcells stimulated for
72hwerealsocrosslinkedwith formaldehydeandanalyzedby
western blotting (Figure 5C). These data show that a protein
that is detectable with an anti-Xirp1 antibody is induced
during cell-cycle entry and becomes bound to C/NM. The
induction of this protein was prevented by transfecting
the cells with siRNA against Xirp1 (Figure 4A), indicating that
it is indeed Xirp1. eIF6 protein expression was also knocked
down in these experiments using siRNA against eIF6 and this
serves as an additional control for Xirp1 knockdown.
Immunocytochemistry was performed on T cells transfected
with either a control siRNA or siRNA against Xirp1 then
stimulated for 40h with PMA/ionomycin. The control siRNA-
transfected cells show a distinct pattern of Xirp1 staining,
which appears to be localized to the nucleus (Figure 4B).
This pattern is not present in cells transfected with siRNA
against Xirp1, indicating that the staining is due to expression
ofXirp1inthenucleiofhumanTcells.Thenuclearlocalization
of Xirp1 was conﬁrmed using confocal microscopy
(Figure 4C).
Otheractin-bindingproteinswerealsodetectedintheC/NM
fraction, including hnRNP proteins (Percipalle et al, 2002,
2009), BAF proteins (Zhao et al, 1998; Olave et al, 2002),
p54
NRB (Ferrai et al, 2009) and Lamin A/C (Simon et al, 2010).
Theseproteins,alongwithHELLS/Lsh(SMARCA6:SWI/SNF2-
related matrix-associated actin-dependent regulator of chro-
matin) (Lee et al, 2000), were also analyzed by western
blotting (Figure 5). Our data suggest that actin-binding
proteins may be active in the nucleus and other laboratories
have shown a role for these proteins in chromatin remodeling,
transcription and RNA processing (see Percipalle et al, 2009;
Zheng et al, 2009).
Functional analyses of splicing and ribosome
biogenesis during the G0-G1 transition
The most signiﬁcantly upregulated cellular processes for
proteins that become bound to C/NM during cell-cycle entry
are ribosome biogenesis and RNA processing (RNA splicing,
transport, editing, decay and RNA-binding proteins). Proteins
involved in these two processes, respectively, account for 19.2
and19.6%ofproteinsthatincreaseinbindingtoC/NMascells
enter the cell cycle, and MCODE analyses of the protein
interaction map show that the most signiﬁcant subnetworks
are enriched for proteins involved in these functions (see
Figure 3B and Supplementary Table S3). We therefore
investigated the importance of these processes for transition
from quiescence into the cell cycle by inhibiting the induction
oftwokeyproteinsidentiﬁedinourmassspectrometryscreen.
The proteins we chose to target were the splicing factor SF3B2
and eIF6, which is involved in ribosome biogenesis. SF3B2
was identiﬁed as becoming bound to C/NM in our initial mass
spectrometry experiments and veriﬁed by western blotting
(Figure 2C). Although none of the SF3B splicing factors
identiﬁed in subsequent mass spectrometry screens reached
thefold-change cutoffof1.5,wedecided totargetSF3B2asitis
known to be involved early in 30-splice site recognition and
reducing the expression of this protein would be expected to
have profound effects on splicing activity. eIF6 was chosen as
it is involved in 60S ribosome biogenesis and because it was
very highly upregulated during cell-cycle entry.
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not the growth cycle
SF3B2 is a component of the SF3B splicing factor and is
required for the functioning of both the major (U2-type) and
the minor (U12-type) spliceosomes (Will et al, 1999). Since
many genes are induced as cells enter the cell cycle for the ﬁrst
time(Diehnet al,2002), depletingSF3B2wouldbeexpectedto
prevent the expression of these genes and materially affect
programs that are stimulated during the G0-G1 transition.
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Figure 3 Proteins bound to chromatin/nuclear matrix that increase 40h post-stimulation with PMA/ionomycin. The C/NM-bound proteins in T cells in G0 and in 40h
afterstimulationwithPMA/ionomycinwereidentiﬁedbymassspectrometry(LTQ-Orbitrap),asdescribedinthetext.TheC/NM-boundproteinswithaZ-score41.96and
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biogenesis and (3) nuclear pore complex and splicing proteins (see Supplementary Table S3). Source data is available for this ﬁgure in the Supplementary Information.
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expressed in G0, but is induced and becomes C/NM bound
following PMA/ionomycin stimulation (Figure 2C). To study
the requirement for SF3B2 during cell-cycle entry, the
induction of the protein was blocked with siRNA. A pool of
four individual siRNA duplexes reduced SF3B2 expression to
o5% of normal levels, as estimated by western blotting for
SF3B2(Figure6A).Inhibition oftheinductionofSF3B2caused
a marked reduction in the percentage of cells that entered S-
phase (17.2±1.6% with control siRNAversus 7.0±1.7% with
SF3B2 siRNA, mean±s.e.m., n¼15, P-value 3.4 10
 6;
Figure 6D). The percentage of SF3B2-depleted cells in S-phase
5 days post-stimulation had still not reached the level of cells
transfected with control siRNA, indicating that quantifying the
effects of depleting SF3B2 at an earlier time point (day 3) is
valid. The effects on cell-cycle progression were also observed
with three of the four individual siRNA duplexes (Figure 6E),
so it is unlikely that the results are due to off-target effects.
Inhibition of SF3B4 expression also led to a decrease in the
percentage of cells in S-phase (14.8±1.5% with control siRNA
versus 7±1% with SF3B4 siRNA, mean±s.e.m., P-value
8.5 10
 5; Figure 6D). SF3B2 and SF3B4 are both components
of the SF3B splicing complex (Golas et al, 2003) and are both
required for splicing activity. Therefore, these data are
consistent with a requirement for SF3B-dependent splicing
for T cells to enter S-phase. This could be due either to cell-
cycle inhibition in late G1, which prevents cells progressing
from G1 into S-phase, or to inhibition of the cell cycle earlier
duringtheG0to G1 transition but noeffect onthegrowth cycle.
Analyses of the expression of proteins that regulate the cell
cycle showed that depletion of SF3B2 prevented the induction
of cyclin D3, which normally occurs early in G1 once T cells
have passed the G0-G1 CP (Lea et al, 2003) (Figure 6A).
SF3B2 inhibition also prevented the phosphorylation of pRb
on S
807/811, which is dependent on cdk4/6-cyclin D and
normally occurs within 16h of PMA/ionomycin stimulation
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Figure 4 Analysis of XIRP1 expression and localization in primary human T cells. (A) The expression of XIRP1 in quiescent T cells and T cells stimulated for 16 and
45h via CD3/CD28 was determined by western blotting (and see Figure 5B and C). Duplicate sets of transfections of quiescent T cells were carried out with siRNA
against XIRP1, or non-targeting siRNA or siRNA against eIF6 as controls, prior to stimulation for the times shown. All samples were run on the same blot.( B) The
localization of XIRP1 in T cells stimulated with CD3/CD28 for 40h was determined by immunoﬂuorescence. The cells analyzed were either transfected with control
siRNA (left panel) or XIRP1 siRNA (right panel). Cells were counterstained with DAPI to show the location of nuclei. (C) Induction and nuclear localization of XIRP1 was
conﬁrmed by confocal microscopy of quiescent T cells and cells stimulated for 40h with CD3/CD28. Z-depth was set to reveal the center of nuclei and the bottom panel
shows a single optical slice taken through one nucleus. Source data is available for this ﬁgure in the Supplementary Information.
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phosphorylation and the lack of cyclin D3 expression are
consistent with inhibition of the transition from quiescence
into the cell cycle (Lea et al, 2003). E2F-1 is normally induced
later in G1 and activation of this transcription factor is
necessary for the induction of many genes encoding proteins
required for cell-cycle progression, for example, Mcm7 (Orr
et al, 2010), Cdc6, Cdc2 (Cdk1) and cyclin A2 (DeGregori et al,
1995). The induction of E2F-1 and its downstream targets
CCNA2 (cyclin A2) and CDC6 were not detected in SF3B2-
depleted cells after 72h of PMA/ionomycin stimulation
(Figure 6A). These data show that SF3B-depleted cells are
prevented from entering the cell cycle, but are still capable of
an increase in size, consistent with entry into the growth cycle
(Zetterberg, 1996).
In order to enter the growth cycle, a cell must increase
protein synthesis, which is largely mediated through the
mammalian target of Rapamycin (mTOR) (see Supplementary
FigureS5fornormalkineticsofinductioninTcells).mTORisa
direct downstream target of protein kinase B (PKB) and is
phosphorylated on S
2448 in response to growth factor stimuli
(Nave et al, 1999). Inhibition of SF3B2 induction with siRNA
did not signiﬁcantly reduce the amount of detectable
phosphorylation of mTOR
S2448 and had little effect on the
phosphorylation status of 4EBP1 (Figure 6B). Cells in G0 are
normally prevented from initiating 50 cap-dependent protein
synthesis by the presence of a hypophosphorylated form of
4EBP1, so the presence of a phosphorylated form of 4EBP1
T37/46
in SF3B2-depleted cells that have been stimulated with PMA
and ionomycin is evidence that these cells have entered the
growth cycle. No change was detected in the amount of
phosphorylated eIF4E
S209 when SF3B2 was depleted
(Figure 6B). Depletion of SF3B4 also had the same effects
(Figure 6C), suggesting that the effects observed are due to an
inactivation of the SF3B splicing complex rather than to the
depletion of SF3B2 or SF3B4 speciﬁcally. The increase in size
in SF3B2/4-depleted cells was identiﬁed by ﬂow cytometry
analyses of protein content (Figure 6D), and the western blot
analyses are conﬁrmatory evidence that proteins involved in
regulating cell growth, for example, 4EBP1 and eIF4E are
phosphorylated in SF3B2/4-depleted cells. Taken together,
these data show that SF3B is required for entry into the cell
cycle, but not for entry into the growth cycle. Furthermore,
these data show that entry into the cell cycle and growth cycle
are separable in primary Tcells.
Reducing eIF6 affects the growth cycle but not the
cell cycle
There is a signiﬁcant increase in the rate of protein synthesis
during the G0-G1 transition accompanied by a four-fold
increase in ribosome number (Ahern and Kay, 1971). A three-
to four-fold increase in protein content occurs as cells progress
from G0 to M-phase for the ﬁrst time (Supplementary Figure
S1A) and proliferating cells must double in size during
progression through the cell cycle to maintain cell size with
each division. The eIF6 protein is required for 60S ribosomal
subunit biogenesis. eIF6 is not expressed or expressed at a low
level in quiescent T cells and becomes expressed in mid-G1
(16hpost-stimulation; Figure4A).Inhibition ofeIF6induction
in G1 would be expected to reduce the number of ribosomes,
protein synthesis and growth cycle entry. To investigate this
requirement for the increasein cell size during cell-cycleentry,
quiescent T cells were transfected with siRNA against eIF6.
Pools of eIF6 protein exist in cells that turn over slowly and
might be sufﬁcient to maintain 60S ribosomal subunit
biogenesis (Gandin et al, 2008). Therefore, the siRNA-
transfected cells were cultured for 3 days without stimulus to
reduce the background levels of eIF6 and then stimulated with
anti-CD3/CD28 beads. Samples were taken for western
blotting and cell-cycle analysis at day 2 and day 3 following
CD3/CD28 stimulation. Transfection with siRNA against eIF6
causedareductionineIF6expressiontoo5%ofnormallevels
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resultsfound whenSF3B2expressionwasinhibited,inhibition
of eIF6 did not lead to a signiﬁcant reduction in the percentage
of cells entering the cell cycle (cells in S and G2/M-phase:
19.1±3.9% with control siRNA versus 18±3.1% with eIF6
siRNA, mean±s.e.m., P-value¼0.39; Figure 7B). However,
cells that were depleted of eIF6 had lower protein content
(indicates cell size) than cells transfected with control siRNA
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Figure 6 Consequences of reducing SF3B2 expression. (A) Normal quiescent human T cells were transfected with apool of foursiRNA duplexes against SF3B2 with
non-targeting siRNA as control. After stimulation with PMA/ionomycin for 72h, the expression of SF3B2, phospho-pRb
s807/811, cyclin A2, cyclin D3, E2F-1 and Cdc6
was detected by western blotting, with GAPDH as a loading control. (B) The expression of phospho-mTOR
S2448, phospho-4EBP1
T37/46 and phospho-eIF4E
s209 was
detected in T cells transfected and stimulated as in (A). (C) T cells were transfected with a pool of four siRNA duplexes against SF3B4 or with non-targeting siRNA as
control.Thecellswere stimulated withPMA/ionomycinandtheexpressionofSF3B4,phospho-pRb
s807/811,cyclinA2,E2F-1,Cdc6, phospho-4EBP1
T37/46andphospho-
eIF4E
s209 were detected by western blotting. (D) T cells transfected and stimulated as in (A, B) were ﬁxed with ethanol, stained with PI (DNA content) and FITC (total
protein content as a measure of cell size; see main text) and the proportion of cells in each of the cell-cycle phases indicated in the ﬁrst panel was determined by ﬂow
cytometry.Asampleofcellstransfectedasin(A)wasalsosampledafter5daysincultureandanalyzedinthesameway.Thepercentagesforthisexperimentareshown
and the mean±s.e.m. for all repeat experiments is indicated in the text. (E) Quiescent T cells were transfected with each of the four individual siRNA duplexes then
stimulated for 72hwith PMA/ionomycin. Thepercentage ofcells ineachcell-cycle phase wasdetermined byﬂowcytometry asdescribedin (D).Source datais available
for this ﬁgure in the Supplementary Information.
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ﬂuorescence intensity of FITC staining (used as a measure of
protein content) of cells that had entered S and G2/M-phases
was signiﬁcantly reduced when eIF6 was depleted
(484.42±3.36 with eIF6 siRNA versus 626.43±22.7 with
control siRNA, mean±s.e.m., P-value¼0.008, n¼3;
Figure 7B). It is interesting to note that the variability in the
protein content of cells, as indicated by the range of FITC
staining (see Figure 7B; y axis) in S and G2/M was much
reduced when eIF6 was depleted (range: 454±33 with eIF6
siRNA versus 638.5±12 with control siRNA, mean±s.e.m.,
n¼3). Thus, we show not only that reducing an important
intracellular protein affects the average size of T cells in
SþG2/M, but the range of cell size is decreased by depleting
eIF6. The molecular mechanisms in T cells controlling the
range of protein content remain to be investigated.
The reduction in cell size observed in eIF6-depleted cells
suggests an inhibition of protein synthesis. There was a
signiﬁcant decrease in the amount of eIF4E
S209 and 4EBP1
T37/46
in eIF6-depleted cells, along with a reduction in mTOR
s2448
(Figure 7A). This strongly suggests an inhibition of 50 cap-
dependent protein synthesis, which would explain the
observed reduction in cell size and protein content. The
expression of proteins involved in cell-cycle entry was also
studied by western blotting. Mcm7 was induced normally in
both control and eIF6-depleted cells (Figure 7A), indicating
that depletion of eIF6 did not affect the ability of cells to enter
S-phase,asshownbycell-cycleanalyses(Figure7B).However,
phosphorylation ofpRbonS
807/811wasdetectedatlowerlevels
and cyclin A2 was not detected in cells that had been depleted
of eIF6(Figure7A). Thesedatashowthat cellsdepletedof eIF6
are able to express and activate some proteins required for
entry into the cell cycle, but have a reduction in the activation
of proteins that are required for the initiation of protein
synthesis.Thus,cellswhicharesmallerandwithlowerprotein
content than normal are nevertheless capable of entering the
cellcycle,showingthatthereisnotanobligatecouplingofcell-
cycle progression with cell size, which human Tcells achieve
under normal conditions.
Discussion
The data presented here show that identifying proteins that
bind to C/NM as cells enter the cell cycle can be used to
determine changes in protein interaction networks that occur
during the re-programming of a cell from a quiescent to an
actively cycling, activated state. These networks include
chromatin remodeling, transcription, RNA processing, ribo-
some biogenesis, DNA replication and structural elements,
such as nuclear actin-binding proteins and components of the
nuclear matrix. Proteins in these networks identiﬁed in our
study as well as speciﬁc predicted subnetworks are discussed
in detail in Supplementary Discussion.
In addition to identifying protein interaction networks, we
carried out siRNA experiments, which show that it is possible
to decouple cellular programs (the cell cycle and the growth
cycle) that are normally tightly regulated. This builds on a
previous study carried out in our laboratory, which showed
that T cells could undergo functional activation without
entering the cell cycle (Lea et al, 2003).
Inhibition of the induction of SF3B prevents entry
into the cell cycle but not the growth cycle
Reducing the expression of SF3B2 or SF3B4 to o5% of normal
levels prevented T cells entering the cell cycle. This was
expected as many genes are induced de novo during entry into
G1 (Diehn et al, 2002 and data presented here), including a
number required for cell-cycle entry. However, it would be
expected that other processes, such as entry into the growth
cycle,wouldalso beaffectedbya reduction in splicing activity.
Rather, the data presented here show that cells depleted of
either SF3B2 or SF3B4 do still increase in size and protein
content, indicating that these cells are still capable of entering
the growth cycle. This suggests that the pre-spliced mRNAs
encoding proteins necessary for growth are already present
during G0. This is borne out by an analysis of mRNA
expression in quiescent T cells (Supplementary Table S7).
These data show that the top 100 most highly expressed
mRNAs in G0 include those encoding proteins involved in
translation (including mRNA encoding 7 initiation factor
subunits), ribosome proteins and cytoskeletal proteins. There-
fore, mRNAs are already present in G0 and do not need to be
transcribed. Furthermore, we demonstrate that at least 45
translation initiation and elongation factors are already
present in quiescent cells (listed in Supplementary Table S7).
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fore support the hypothesis that mRNAs encoding translation
initiation and elongation factors, involved in control of the
growthcyclearealreadypresentinquiescentcellsandarethus
probably unaffected by a reduction in splicing activity.
A number of translation factors, such as eIF4E, are further
induced during the G0-G1 transition by mitogenic stimula-
tion (Supplementary Table S2; Supplementary Figure S5;
Rosenwald et al, 1993), but the mRNAexpression data suggest
that quiescent Tcells are primed to enter the growth cycle, but
splicing of de novo transcripts that are induced in G1, such as
MCM7 (Orr et al, 2010), is required for cells to enter the
cell cycle.
Depletion of eIF6 allows entry into the cell cycle at
reduced cell size
WeshowedherethatTcellsinwhicheIF6hasbeenreducedare
able to enter the cell cycle, but they do so at a restricted size.
Studies of yeast demonstrated that eIF6 is involved in the
biosynthesis of the large (60S) ribosomal subunit (Fatica and
Tollervey, 2002; Horsey et al, 2004; Volta et al, 2005). In higher
eukaryotes, reducing eIF6 expression in mouse ﬁbroblasts to
about 20% of normal using siRNA did not affect ribosome
biogenesis as a pool of nucleolar eIF6 remained (Gandin et al,
2008). Cells depleted of eIF6 by siRNA treatment have
sufﬁcient ribosomes to translate the proteins necessary for
survival and core metabolic processes, but are not capable of
responding normally to a mitogenic stimulus. However, a
homozygous EIF6 knockout is embryonic lethal and it was
concluded that eIF6 is necessary for ribosome biogenesis.
Under normal, non-limiting conditions, increase in cell size
andproteincontentkeepsin stepwith progression throughthe
cell-cycle phases so that cellular homeostasis is maintained
with each cell division. However, work on Schwann cells
showed that the homeostatic cell size can be changed over
several cell divisions by limiting the availability of extra-
cellular factors (Conlon and Raff, 2003). Cell divisions that do
not result in cell growth occur during Xenopus and Drosophila
embryonic development, although the mechanisms in Droso-
phila and mammalian cells that regulate cell growth and
proliferation are different (Montagne et al, 1999; Miron et al,
2001;ConlonandRaff,2003;Ohannaetal,2005;Dowlingetal,
2010). The data presented here show that if endogenous levels
of eIF6 in human quiescent T cells are reduced and the
induction of eIF6 that normally occurs in response to CD3/
CD28 stimulation is inhibited, the cells enter the cell cycle as
normal but at a reduced size. This indicates that T cells are
capable of progressing through the cell cycle when protein
content and cell size is restricted, even in the presence of non-
limiting conditions of extracellular stimuli, showing that
progression through the cell cycle is coincident with but not
completely dependent on cell size. The role of eIF6 is to
prevent the premature association of the 60S and 40S subunits
(Valenzuela et al, 1982), leading to the accumulation of
inactive 80S particles (Gandin et al, 2008), which would
sequester 40S subunits. So, reducing eIF6 will reduce the
availability of 40S ribosome subunits to initiate translation.
Our data show that the mTOR/eIF4E/4EBP1 pathway is also
affected by reducing eIF6, although the mechanisms remain to
be determined. The role of mTORC1 in mediating proliferation
but not cellular growth by affecting the selection of mRNA
translated was shown recently (Dowling et al, 2010).
The roles of initiation factors are complexand there are no a
priorirulesastotheeffectsthataparticularfactormayhaveon
cell growth and proliferation. For example, eIF4B depletion in
cancer cells attenuates proliferation (Shahbazian et al,
2010a,b) but not cell size (Dowling et al, 2010). Reduction in
proliferation involves the selective translation of mRNA
encoding proteins, such as cyclin D3, ODC and VEGF. In
contrast, eIF4GI depletion impairs cell proliferation and cell
size in MCF10A breast epithelial cells, while depletion or
overexpression of other eIF4G family members does not
(Ramirez-Valle et al, 2008). Depletion of eIF4GI isoforms in
HeLa cells causes mitotic abnormalities, including multi-
nucleated cells (Coldwell and Morley, 2006). So, abrogation of
translation factors have different effects and it is not expected
that eIF6wouldnecessarilyaffect cell growthbut notcell-cycle
progression. In addition, splenic pre-B cells in EIF6
 /þ mice
have a small reduction in the percentage of S-phase cells and
an increase in G0/G1 cells in response to induction of Myc, but
this did not occur in pre-B cells in the bone marrow. However,
cell size was not measured (Miluzio et al, 2011). Therefore,
reducing the level of a eukaryotic initiation factor (haploin-
sufﬁciency in EIF6) decreases proliferation of pre-B cells but
only in the spleen and not the bone marrow.
The consequences of a defect in eIF6 function are illustrated
by Shwachman–Bodian–Diamond syndrome. Clinical features
include exocrine pancreatic insufﬁciency, defects in hemato-
poeisis and a predisposition toward leukemias, in particular
myelodysplastic syndrome (MDS) and acute myeloblastic
leukemia (AML) (Woods et al, 1981; Dror et al, 1998). There
are also effects on lymphocyte-mediated immunity, including
decreased B-cell proliferation, reduction in the number of T
cells in the peripheral blood and defects in the CD4/CD8 ratio
(Dror et al, 2001). This is an autosomal recessive disorder,
caused by mutations in the SBDS gene (Boocock et al, 2003),
and no abnormalities in EIF6 have been reported. The function
of the protein encoded by the SBDS gene was determined by
studies on its ortholog in yeast, Sdo1 (Menne et al, 2007).
Mutations in this gene lead to defects in 60S ribosome
biogenesis, with the nuclear retention of pre-60S ribosomes
that would normally be exported to the cytoplasm (Menne
et al, 2007). This effect was reversed by gain-of-function
mutants of Tif6, which is the yeast ortholog of human EIF6.
Two important papers on mammalian eIF6 were published
recently. The ﬁrst describes the mechanism in Shwachman–
Bodian–Diamond syndrome involving SBDS, EFL1 and eIF6
in late cytoplasmic ribosomes, catalyzing translational activa-
tion (Finch et al, 2011). The second shows a role for eIF6
in response to growth factors and its requirement for
lymphomagenesis (Miluzio et al, 2011).
We have shown here that a high-throughput mass spectro-
metryapproachcanbeusedtoidentifyregulatorymechanisms
involved in the re-programming of Tcells during the G0-G1
transition. We have also shown that cell-cycle entry can be
dissociated from entry into the growth cycle by inhibiting
the induction of the splicing factors SF3B2/SF3B4 or the
ribosome biogenesis factor, eIF6. There are a number of other
Tcell protein interaction networks during cell-cycle entry
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in our study, for example, solute carriers, nuclear pore
complex proteins and others (Supplementary Results and
discussion). Such subnetworks are likely to have important
roles in re-programming quiescent Tcells to enter the cell and
growth cycles and to become activated. A combination of
stringent bioinformatic predictions of binding partners of
proteins in these subnetworks as well as wet-lab conﬁrmation
and analyses of the roles of such subnetworks in the G0-G1
transition will no doubt shed further light on the integration of
cellular programs necessary for peripheral T-cell expansion
and functional activation.
Materials and methods
T-cell isolation and stimulation
Normal, non-activated, quiescent human T cells were isolated by
negative selection (Dynal, Invitrogen) from single-donor buffy coats
(Lea et al, 2003) and assays to analyze T-cell activation and cell-cycle
progression were as described in Lea et al (2003).
Isolation and trypsinization of chromatin/nuclear
matrix proteins
Non-activated or stimulated T cells from four individual donors
(biological replicates) (usually 3 10
7 cells) were pelletted and
resuspended in 20ml/10
6 cells ice-cold CSK buffer (10mM PIPES pH
6.8, 100mM NaCl, 300mM sucrose, 1mM MgCl2, 1mM EDTA, 0.1%
(v/v) Triton X-100, 0.1mM ATP, protease and phosphatase inhibitors
(Complete,Roche))asdescribed(Leaetal,2003).Theinsolublepellet,
containing chromatin/nuclear matrix-bound proteins (Krude et al,
1996), was centrifuged at 1000g and washed 3  with 50ml PBS. The
CSK-soluble proteins (‘free’ fraction) were precipitated by adding four
volumes of  201C acetone. Both ‘free’ and ‘chromatin’ pellets were
resuspended in 10mM Tris–HCl pH 7.8, 10mM KCl, 1.5mM MgCl2.
Residual Triton X-100 was removed with the OrgoSol DetergentOUT
Detergent removal kit (G-Biosciences). Following detergent removal
and resuspension, proteins were denatured by addition of triﬂuor-
oethanol (TFE) to 50% (v/v). Proteins were reduced (15mM DTT at
561C for 45min) and alkylated (55mM iodoacetamide at 251C for
30min). Samples were diluted 10-fold with digestion buffer (50mM
Tris–HClpH7.8,2mMCaCl2)todecreasetheTFE concentrationto5%
(v/v). Each sample was treated with 2mg Proteomics Grade trypsin
(Sigma) and incubated at 371C for 4h. Trypsin activity was halted by
the addition of 1% formic acid, and sample volume was reduced to
B20ml by SpeedVac centrifugation. Samples were resuspended to
150ml with Buffer C (95% H2O, 5% acetonitrile (ACN), 0.1% formic
acid). To remove undesirable contaminants, digested samples were
cleaned up by reverse phase chromatography on Hypersep C18
Columns (Thermo) and ﬁltered on Microcon 10kDa Spin Tubes
(Centricon) prior to LC-MS/MS.
Mass spectrometry
LC/MS/MS analysis was carried out on an Eksigent nanoﬂow LC
system connected to an LTQ-Orbitrap XL (Thermo). Four injections
were carried out per sample. Tryptic peptide mixtures were separated
online by reverse phase chromatography on a Zorbax C18 reverse
phase column (Agilent) by 5–38% ACN gradient over the course of
230min. Eluted peptides were directly injected by electrospray
ionization into an LTQ-Orbitrap XL hybrid mass spectrometer
(Thermo) equipped with a nano-spray ion source for analysis. Full
spectra (MS1) were collected at 100000 resolution. Ion fragmentation
spectra (MS2) were collected in a data-dependent manner, with ions
required to carry þ2 or greater charge for MS2 selection. The top 12
most intense qualifying peaks were selected per round, with peaks
selected twice within 30s excluded from selection for 45s. Spectra
were searched using the Sequest search algorithm against the non-
redundant Ensembl 57 Homo sapiens (NCBI36) protein-coding data
set. Search results were submitted to PeptideProphet (Keller et al,
2002) and ProteinProphet (Nesvizhskii et al, 2003) via TPP (Keller
et al, 2005) and ﬁltered to 1% false positive rate using a target-decoy
method with a reverse-concatenated database.
Bioinformatic analysis
Generation of protein lists
For each biological replicate fraction, four separate LC-MS/MS
injections were performed and analyzed independently. Data sets
corresponding to the same biological replicate fraction were then
merged, with spectral counts summed within each set. All data sets
were aligned, and proteins observed in only one biological replicate
fraction were removed. Keratins were also removed from the data set.
To account for the occurrence of degenerate peptides assigned to
multiple proteins, the data set was curated to assign all peptides to a
single unique protein or protein group. Protein groups consisted of the
smallest set of proteins needed to account for non-unique peptide
identiﬁcations, whereby all group members shared equal evidence of
occurrence.
Protein quantiﬁcation
Proteins were quantiﬁed by comparison of spectral counts, as
described in Lu et al (2007) and Vogel and Marcotte (2008). In
summary, frequencies of observation were calculated from spectral
counts for each protein in each biological replicate fraction, and
individual Z-scores were calculated bycomparing frequencies at 0 and
40h time points to determine the statistical signiﬁcance of differences
in relative abundance (Lu et al, 2007; Vogel and Marcotte, 2008).
A z-score of ±1.96, corresponding to a P-value o0.05, was used as a
determinant of signiﬁcance. Composite Z-scores for free and bound
fractions were then calculated from the individual Z-scores for each
biological replicate. Fold-change was estimated as a ratio of
frequencies of observation for each protein at 0 and 40h time points.
Foreach protein,a pseudo-countof1 wasaddedto eachspectral count
total prior to frequencycalculations in order to adjust for proteins with
a zero-count.
Ontology annotations
Each protein was assigned a function by GO annotation (http://
www.geneontology.org) andthe functional categories usedfor the pie-
chart shown in Figure 3A and Supplementary Figure S2 were curated
based on reading the primary literature for each protein (see
Supplementary Review of T-cell proteomics).
siRNA and transfection
Pools of SF3B2, SF3B4 and control siRNA (SmartPool, Dharmacon), or
each of four individual siRNA (siGenome, Dharmacon) or stabilized
siRNA (Stealth, Invitrogen) were transfected into quiescent primary
human T cells by electroporation (Nucleofection, Amaxa) (Orr et al,
2010). Sequences of the siRNA used are shown on the next page
(antisense sequences).
Cells transfected with siRNA were cultured overnight without
stimulus to recover, stimulated with PMA/ionomycin and samples
were typically taken 72h later for further analyses. Samples were also
analyzed at other time points up to 128h (5 days) later, as indicated in
the text. For eIF6, the siRNA-transfected cells were left in culture for 3
days to deplete low levels of endogenous protein present in quiescent
cells before stimulation. The level of SF3B2 or eIF6 protein expressed
after siRNA transfection was determined by western blotting using
2 10
5 cells per well and the signal obtained was compared with
incremental amounts of the sample transfected with control siRNA
(4 10
3–2 10
5 cells, that is, 2–100% of the SF3B2 siRNA-transfected
cells) that was run on the same blot.
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Western blotting was carried out with 4–12% (w/v) polyacrylamide
Bis-Tris gels (Invitrogen-Novex). Antibodies used were Apobec 3C
(C8-1,ProfessorNeuberger,MRC,Cambridge,UK);BAF53(DrMichael
Cole, Dartmouth College, USA); HnRNP-K (C-terminus, Professor
Bomsztyk, U Washington, USA); p68 (DDX5) (PAb204, Upstate; from
Professor Frances Fuller-Pace, Dundee, Scotland); Prohibitin (Ab-1,
Neomarkers; from Professor Eric Lam, Imperial College, London);
RUNX3(ProfessorPaulFarrell,ImperialCollege,London);SAFB1(DrS
Osterreich, MD Anderson, Houston, TX, USA); Topoisomerase I (C21,
BD-Pharmingen; from Dr Andrew Porter, Imperial College, London);
MeCP2 (ab3752), HP1g (ab10480), Histone H3 (ab1791) SF3B4
(ab11803) (Abcam); cyclin A2 (BF683), NF-kB-p50 (K10-895.12.50),
PARP-1 (C2-10), pRb (PMG3245), STAT3 (Ab-84) (BD-Pharmingen);
p54
nrb (611278), BAF190 (610390), Mcm2 (BM28) (BD Transduction
Laboratories); eIF6 (#3263; from Professor Alan Warren, University of
Cambridge); p44/42 MAP kinase; phospho-mTOR (S
2448), phospho-
eIF4EBP1 (T
37/46), phospho-eIF4E (S
209), RPS6 (#2317) (Cell Signaling
Technology); GAPDH (MAB374), PP1-a (AB4082, Chemicon); phos-
pho-pRb(S
807/811) (New England BioLabs, Hertfordshire, UK); Aly/
THOC4 (sc-32311), cdc2 (Cdk1) (17), Cdc6 (C19), cdk6 (C21), cyclin
D3 (C16), E2F-1 (C20), HELLS/Lsh (H-4, sc-46665), Lamin A/C (N-18;
sc-6215), SAM68 (C20), Xin1/Xirp1 (D8, T-20) (Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA); hnRNP-A2/B1 (DP3B3), Mcm7 (DCS
141) (Sigma); LSP-1 (Ab-16) (Transduction Laboratories). In the
course of this study, western blot membranes were either routinely cut
into sections and each section probed with a different antibody or the
blots were re-probed sequentially with different antibodies, which
recognize proteins of different molecular weights (e.g., Mcm2 and
Mcm7). Sections of the ﬁlms that showed the bands corresponding to
each antibody (determined by size comparison with molecular weight
markers) were selected in the scanner software (Epson Scan 3.04),
scanned individually as separate image ﬁles and saved as JPEGs. In
some cases, changes in brightness and/or contrast were applied
linearly equally across the entire image. These are available as Source
Data.
Immunoﬂuorescence
Cytospin preparations of 40000 T cells were made on poly-lysine-
coated microscope slides (Shandon Cytospin 4 (Thermo)). Slides were
ﬁxed in 2% (w/v) paraformaldehyde for 30min at room temperature,
washed three times with PBS and stored immersed in PBS at 41C. Cells
were permeabilized with 0.2% (v/v) Triton X-100 in PBS for 10min at
room temperature, washed three times in PBS, blocked in PBS/10%
(w/v) BSA and washed three times with PBS. Slides were incubated
overnight with 1/100 Xirp1 antibody in blocking solution at 41C,
washed three times with PBS, incubated for 1h in 1:200 TRITC-
conjugated donkey anti-goat secondary antibody (Jackson Labora-
tories) in blocking solution, then washed as above. Cells were
counterstained with a DNA stain (DAPI), rinsed in PBS, mounted
using Antifade and analyzed with an Olympus (Provis AX70,
Olympus) ﬂuorescent microscope with DAPI/FITC/rhodamine triple
pass ﬁlters. Confocal microscopy and Z-stacks of 50 optical slices was
performed using a Leica DMIRE2 instrument (with thanks to Dr M-J
Bijlmakers, Immunology Department, KCL).
Gene expression analysis
Gene expression arrays (U133A, Affymetrix) were probed with RNA
isolated from at least four biological replicates of T cells in G0 and at
timepointscorrespondingtocellsduringtheG0-G1transition(1–8h),
mid/late G1 (24 and 32h) and later in the ﬁrst cell cycle (48h). The
procedures were according to the manufacturer’s protocols (one-round
ampliﬁcation; Affymetrix). Data were normalized using the VSN
algorithm (version 3.2.1) (Huber et al, 2002) implemented in
Bioconductor(Biobase/Affymetrixversions1.16.2/1.16.0)(Gentleman
et al, 2004) and R version 2.6.1 (Dessau and Pipper, 2008). The probe
sets were mapped on the ENSEMBL (Hubbard et al, 2009), NCBI 36
assembly, allowing for one alignment error between the probe and
transcripts sequences. Probe sets containing probes matching
more than one gene, or which matches contained alignment errors,
were ignored for further analysis. The ﬁnal expression values were
averaged over replicated time points, and over probe sets reporting the
same gene.
Protein interaction network analysis
A network consisting of human protein–protein interaction pairs
was generated using HumanNet (http://www.functionalnet.org/
humannet/) (Lee et al, 2011a,b). HumanNet is a probabilistic
functional gene network derived from the integration of large-scale
‘omics’ data sets across multiple species. Proteins showing signiﬁcant
changes in abundance (1.96 XZ-score p 1.96, fold-change X2) in
the bound and unbound fractions were mapped onto the network and
visualized using Cytoscape (http://www.cytoscape.org).
Biological replicate experiments and statistical
analysis
Each experiment was carried out with cells isolated from at least three
independent donors (n¼X indicates X independent donors). Results
are expressed as mean±standard error of the mean for the n¼X
experiments. The signiﬁcance of differences between conditions was
assessed by the Students ‘t’-test.
Archiving mass spectrometry and microarray data
All mass spectrometry data described in this paper are publically
available through PeptideAtlas (http://www.peptideatlas.org/PASS/
PASS00016). Microarray data have been deposited in GEO with the
accession number GSE32607.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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